New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 7, 2012
16:38 EDTCECO, DIS, TPX, VRTX, CTSH, ABTOn The Fly: Closing Wrap
Stocks on Wall Street were mixed, as investors had a muted reaction to the anti-austerity backlash evidenced in two elections in Europe. Stock futures pointed to a lower open throughout the pre-market trading session but moved off their low prior to the opening bell. The futures action led to a lower but stable open with the market essentially hitting its lows soon after the open. The market began to drift off its lows after the first hour of trading and by midday made it back to positive ground. The market continued to drift for most the remainder of the session until a downturn into the close pushed the S&P and Nasdaq back down to finish the day near the flat line... ECONOMIC EVENTS: In the U.S., consumer credit increased by $21.36B in March, versus expectations of an increase of $9.8B. In Europe, Francois Hollande defeated Nicolas Sarkozy in France's presidential election and voting in Greece’s general election showed a dramatic swing toward anti-austerity groups and away from the pro-Europe parties... COMPANY NEWS: Disney's (DIS) "The Avengers" set U.S. records with its $200M opening weekend, powering the company's shares 2% higher... Abbott Labs (ABT) announced it reached a settlement and will pay $1.6B in connection with its marketing of Depakote... MAJOR MOVERS: Among the notable gainers were Vertex Pharma (VRTX), up $20.71, or 55.36%, to $58.12, amid at least three upgrades and a number of price target increases after the company reported interim data from a Phase 2 study of a combination therapy for certain cystic fibrosis patients, and Career Education (CECO), up 56c, or 8.70%, to $7.00, after the Accrediting Council for Independent Colleges and Schools removed its show-cause directive on all 71 Career Education campuses accredited by the body and the company said four of its campuses were placed on probation. Noteworthy losers included Cognizant (CTSH), down $13.35, or 19.16%, to $56.31, after the company's earnings beat consensus but it said its revising its guidance to be more conservative after seeing slower-than-expected acceleration in demand, and Tempur-Pedic (TPX), down $8.42, or 14.85%, to $48.29, as Raymond James said in a note to investors that the company will offer a discount on one of its most profitable mattresses, the Cloud Supreme, which the firm said was unusual for the company... INDICES: The Dow lost 29.74, or 0.23%, to 13,008.53; the Nasdaq rose 1.42, or 0.05%, to 2,957.76; and the S&P 500 added 0.48, or 0.04%, to 1,369.58.
News For DIS;ABT;VRTX;CECO;CTSH;TPX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 21, 2015
13:34 EDTDISEarnings Watch: Yahoo shares dropped more than 6.5% since last earnings report
Subscribe for More Information
13:34 EDTVRTXGilead paying premium to buy Vertex not warranted right now, says Maxim
After Bernstein suggested in a note to investors earlier that Gilead (GILD) should buy Vertex (VRTX), Maxim responded in its own note that it does not believe paying a premium to buy Vertex makes sense before the company has data showing efficacy for Kalydeco in heterozygotes. Maxim keeps a Hold rating and $121 price target on Vertex shares.
12:33 EDTVRTXOn The Fly: Top stock stories at midday
Subscribe for More Information
12:21 EDTVRTXVertex rises after Bernstein suggests Gilead should pursue takeover
Subscribe for More Information
08:14 EDTVRTXGilead should buy Vertex, says Bernstein
Subscribe for More Information
April 20, 2015
17:04 EDTDISOn The Fly: Top stock stories for Monday
Stocks on Wall Street were higher for the day, beginning the session sharply higher and remaining in positive territory throughout. China’s central bank announced a reduction in bank reserve requirements in an effort to increase liquidity and spur economic growth within the country. Following the open, the market moved in a relatively narrow range as investors await the latest round of earnings reports for one of the season's heavier weeks. ECONOMIC EVENTS: In the U.S., the Chicago Fed National Activity Index came in at 0.42 versus expectations for positive 0.1. In Asia, the People's Bank of China lowered its reserve requirement ratio, by 1 percentage point, the lowest since the financial crisis. Despite this, the Shanghai Composite Index fell 1.6% because regulators had already begun curbing speculative trading on Friday. COMPANY NEWS: Morgan Stanley (MS) advanced 0.57%, or 21c, to $36.96 after reporting earnings prior to the market open. The bank beat on both EPS and revenue, and also raised its dividend to 15c from 10c. CEO James Gorman was pleased with the quarter and cited growth across the majority of the company's operations. MAJOR MOVERS: Among the notable gainers was Hasbro (HAS), which rose 12.55% to end the session at $74.16 after reporting EPS and revenue in excess of analyst expectations. During its earnings conference call, the company appeared confident on its 2015 offerings which include Disney (DIS) Princess and Frozen product lines. Also higher was Rovi (ROVI), gaining 8.64% to close the day at $19.11 after renewing its licensing and program guide agreement with Charter (CHTR). Among the noteworthy losers was Caesars Entertainment (CZR), tumbling 17.01% to $10 after failing to reach an agreement on its restructuring. Also lower were a number of medical companies involved in the development of CAR-T cancer therapies, including Kite Pharma (KITE), Juno Therapeutics (JUNO), blue bird bio (BLUE), and ZIOPHARM Oncology (ZIOP). The drop followed disappointing, small-scale studies presented during the annual meeting of the American Association for Cancer Research. INDEXES: The Dow rose 208.63, or 1.17%, to 18,034.93, the Nasdaq advanced 62.79, or 1.27%, to 4,994.6, and the S&P 500 gained 19.22, or 0.92%, to 2,100.4.
06:03 EDTDISESPN raises objections to Verizon FiOS TV packages, WSJ reports
Subscribe for More Information
April 17, 2015
16:11 EDTDISOptions Update; April 17, 2015
Subscribe for More Information
08:03 EDTTPXH Partners urges Tempur Sealy shareholders to vote against TS directors
Subscribe for More Information
07:00 EDTDISDisney price target raised to $120 from $105 at Jefferies
Subscribe for More Information
April 16, 2015
08:11 EDTTPXTempur Sealy backs annual adjusted EPS growth of 15% for 2015-2018
Backs annual net sales growth of 6% for 2015-2018. Backs annual operating margin improvement of 50 basis points for 2015-2018. Backs outlook of 3x leverage, with strong cash flow to return value to shareholders from 2015-2018. The company expects to generate $125M in operating income improvement by 2018 by making progress against four specific operational objectives: driving gross margin improvements for Sealy U.S.; achieving additional cost synergies from the Sealy acquisition; reducing adjusted operating expense as a percentage of revenue from 29% in 2014 to 28% by 2018; and implementing an enhanced 2015 pricing strategy. The company reiterated the confidence in its future and value creation in a letter mailed to shareholders.
08:01 EDTDISJPMorgan positive on Disney into Q2 earnings report
Subscribe for More Information
07:13 EDTDISDisney and Corus Entertainment sign licensing agreement in Canada
Subscribe for More Information
April 15, 2015
09:02 EDTDISDolby Vision to launch with Disney's Tomorrowland, Disney Pixar's Inside Out
Dolby Laboratories (DLB) and The Walt Disney Studios (DIS) announced that Disney’s Tomorrowland, in theatres May 22, 2015, and Disney•Pixar’s Inside Out, in theatres June 19, 2015, will be the first Dolby Vision titles to be shown at Dolby Cinema™ locations around the globe. In addition, Disney’s The Jungle Book, due out April 15, 2016, will also be presented in Dolby Vision, with more titles to be announced.
07:41 EDTABTEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 14, 2015
09:06 EDTABTAbbott and Sekisui announce collaboration for coagulation testing
Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests measure a person's blood clotting ability, which can help doctors assess risks of excessive bleeding or developing clots. Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in the United States, Europe and other regions that recognize CE Mark.
April 13, 2015
09:10 EDTTPXMattress sales grew 8.3% in February, ISPA says
Subscribe for More Information
07:22 EDTDISWave of media M&A may be on the way, WSJ says
Subscribe for More Information
April 12, 2015
18:52 EDTDISDisney/ABC Television Group digital chief Albert Cheng leaving, Deadline says
Subscribe for More Information
15:58 EDTDISComcast's 'Furious 7' maintains lead at weekend box office with $60.6M
Rentrak announced the official domestic weekend box office estimates for the weekend of April 12, as compiled by the company's theatrical measurement services. Universal's (CMCSA) "Furious 7" topped the domestic weekend box office with $60M; 21st Century Fox's (FOX, FOXA) "Home" came in second place at the box office with $19M; 21st Century Fox's (FOX, FOXA) "The Longest Ride" came in third place with with $13.5M; Warner Bros.' (TWX) "Get Hard" came in fourth place with with $8.6M and Disney's (DIS) "Cinderella" came in fifth place with $7.2M.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use